Presentation AHA 2017 One-Year Outcomes: Prasugrel vs Ticagrelor in AMI Treated With PPCI PRAGUE-18 Study Presenter: Zuzana Motovska November 11, 2017 REGISTER for free or LOG IN to view this content Coronary ACS/AMI CAD Pharma Presentation AHA 2017 Up Next Presentation AHA 2017 Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program Presenter: Kenneth W. Mahaffey November 14, 2017 More slides + Presentation AHA 2017 Subgroup Analysis from the RE-DUAL PCI Trial Presenter: Jonas Oldgren November 14, 2017 Presentation AHA 2017 The POISE-2 PCI Substudy Presenter: Michelle M. Graham November 14, 2017 We Recommend
Presentation AHA 2017 Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program Presenter: Kenneth W. Mahaffey November 14, 2017
Presentation AHA 2017 Subgroup Analysis from the RE-DUAL PCI Trial Presenter: Jonas Oldgren November 14, 2017